Submit Manuscript  

Article Details


Curcumin Suppresses Epithelial Growth Factor Receptor (EGFR) and Proliferative Protein (Ki 67) in Acute Lung Injury and Lung Fibrosis In vitro and In vivo

[ Vol. 20 , Issue. 4 ]

Author(s):

Sadiya Bi Shaikh, Ashwini Prabhu and Yashodhar Prabhakar Bhandary*   Pages 558 - 563 ( 6 )

Abstract:


Background: Acute lung injury is one of the common conditions caused due to bleomycin therapy which leads to pulmonary fibrosis, which is one of the severe interstitial lung diseases most commonly affecting the elderly individuals. EGFR and Ki67 can be marked as beneficial markers for detecting pulmonary fibrosis based on which clinicians can guide the therapy.

Objective: The aim of the study was to evaluate the effect of curcumin as an intervention on two prognostic markers EGFR and Ki67 in bleomycin-induced basal alveolar epithelial cells and C57BL/6 mice. Protein expressions and pathological expressions of EGFR and Ki67 were evaluated to analyze the effect of curcumin via both in vitro and in vivo approaches.

Methods: The effect of curcumin was investigated both on cell lines (A549) and animal model (both normal and bleomycin-induced mice, n=6) via techniques like western blotting for protein expression. Techniques like immunofluorescence and immunohistochemistry were carried out and examined under confocal microscopy and phase contrast microscopy to analyze the expressions of the said biomarkers. Bleomycin was used as a causative agent to induce inflammation.

Results: The natural polyphenol curcumin could downregulate the expressions levels of Ki67 and EGFR both in vitro and in vivo. Immunofluorescence analysis of proliferative marker Ki67 showed a reduced expression on curcumin treatment in vitro. The pathological sections from treated lungs showed a significant decrease in EGFR and Ki67 levels when exposed to curcumin.

Conclusion: We conclude that curcumin, a well-known natural bioactive compound holds strong antiproliferative effects on Ki67 and EGFR expressions.We observed that a clinical outcome in the diagnosis of pulmonary fibrosis remains to be unconvincing so far. Curcumin can be considered as a potential therapeutic.

Keywords:

Acute lung injury, pulmonary fibrosis, bleomycin, curcumin, Ki67, EGFR.

Affiliation:

Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore – 575 018, Karnataka, Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore – 575 018, Karnataka, Yenepoya Research Centre, Yenepoya (Deemed to be University), Deralakatte, Mangalore – 575 018, Karnataka

Graphical Abstract:



Read Full-Text article